Your chances of a migraine increase with hotter temperatures
Research by Dr. Vincent Martin is featured in national and international media
A change in weather is one of the most common trigger factors for migraine. Hotter temperatures increase the chance of a migraine attack, according to research led by Vincent Martin, MD, director of the Headache and Facial Pain Center at UC’s Gardner Neuroscience Institute.
Martin, also a professor in the UC College of Medicine, spoke with Cincinnati’s Fox 19 News about his latest study findings which looked at use of Fremanezumab and whether it could prevent headaches caused by temperature increases. Produced by Teva Pharmaceuticals USA, Fremanezumab is sold under the brand name AJOVY®, administered by injection under the skin to treat migraines.
A research team led by Martin cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 10 degrees Fahrenheit daily, there was a 6% increase in occurrence of any headache. However, during the time periods of Fremanezumab treatment the association completely disappeared.
Record high temperatures across much of the Midwest and Northeast regions of the country has increased dialogue about health ailments associated with the heat. Martin’s findings were reported on more than 200 media outlets including CBS News, The Atlanta Journal Constitution, The Miami Herald and internationally in publications such as Greece’s Tempo 24, Argentina’s Infobae, Italy’s Agenzia Italia, Mexico’s El Cuarto Poder , Venezuela’s Noticias Venevision and Indonesia’s Suara Merdeka.
Read about the research findings from Vincent Martin, MD, online.
Learn more about migraines and hotter temperatures on CBS News
Featured top image is courtesy of Istock.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.